Key result
High peak NT-proBNP plus non-plaque rupture in STEMI links to higher mortality and improves risk prediction.
Why the study?
Culprit plaque phenotypes and NT-proBNP influence clinical outcomes in ACS, but the prognostic implication of admission peak and baseline NT-proBNP across different plaque phenotypes in STEMI patients remains to be investigated.
Does the combination of admission peak NT-proBNP and culprit plaque phenotype predict MACE and death in patients with STEMI?
Cohort (n=428)
Does the combination of admission peak NT-proBNP and culprit plaque phenotype predict MACE and death in patients with STEMI?
The combination of peak NT-proBNP levels and OCT-derived culprit plaque phenotype improves risk stratification and prediction of death in patients with STEMI.
Answers are grounded in this paper and cite their sources.
May aid STEMI death risk stratification; extends biomarker-plaque data but remains hypothesis-generating pending validation.
Objective: Different culprit plaque phenotypes including plaque rupture (PR) and non-plaque rupture (NPR), and N-Terminal prohormone of brain natriuretic peptide (NT-proBNP) have been reported to influence clinical outcomes in patients with acute coronary syndrome (ACS). We aimed to investigate the prognostic implication of the peak and baseline values at admission for NT-proBNP for major adverse cardiovascular events (MACE) in ST-Segment Elevated Myocardial Infarction (STEMI) patients with different plaque phenotype. Methods: A total of 428 patients with STEMI undergoing optical coherence tomography (OCT) were enrolled and divided into four groups: PR/Tertile1-2 NT-proBNP (n = 132), PR/Tertile3 NT-proBNP (n = 65), NPR/Tertile1-2 NT-proBNP (n = 154), NPR/Tertlie3 NT-proBNP (n = 77). Baseline and Peak values of NT-proBNP were obtained in the admission period. The MACEs were defined as the composite of all-cause death, recurrence of myocardial infarction and stroke. Results: High levels for peak NT-proBNP were significantly associated with a higher incidence of MACE and death (Log rank p = 0.037 and 0.0012, respectively). In the subgroup with NPR, a high level for peak NT-proBNP was significantly associated with higher incidence of death (Log rank p = 0.0022) but this association was not significant in the subgroup of PR (Log rank p = 0.24). Though plaque types were not associated with adverse event, the combination of NPR and a higher peak value for NT-proBNP indicated higher incidence of death compared with other groups (Log rank p = 0.0017). The area under the receiver operating characteristic curve for predicting death to evaluate the diagnostic value of the peak value for NT-proBNP and plaque types combined with traditional risk factors was 0.843 (95% CI: 0.805–0.876), which is superior to solely traditional risk factors: NRI (26.8% [95% CI: 0.4–53.1%], p = 0.046) and IDI (5.1% [95% CI: 1.0–9.2%], p = 0.016). Conclusion: STEMI patients with NPR and a high level for peak NT-proBNP showed higher incidence of death. The peak value of NT-proBNP in combination with plaque types can be used in risk stratification and prediction of death in patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a cohort in ST-Segment Elevated Myocardial Infarction (STEMI) (n=428). Peak NT-proBNP and culprit plaque types (plaque rupture vs non-plaque rupture) vs. Traditional risk factors was evaluated on Major adverse cardiovascular events (MACE) defined as the composite of all-cause death, recurrence of myocardial infarction and stroke (p=0.037). High peak NT-proBNP combined with non-plaque rupture in STEMI patients was associated with a higher incidence of death and improved risk prediction.
Synapse has enriched 10 related papers. Consider them for comparative context: